Literature DB >> 20932473

DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization.

H Christian Reinhardt1, Pia Hasskamp, Ingolf Schmedding, Sandra Morandell, Marcel A T M van Vugt, Xiaozhe Wang, Rune Linding, Shao-En Ong, David Weaver, Steven A Carr, Michael B Yaffe.   

Abstract

Following genotoxic stress, cells activate a complex kinase-based signaling network to arrest the cell cycle and initiate DNA repair. p53-defective tumor cells rewire their checkpoint response and become dependent on the p38/MK2 pathway for survival after DNA damage, despite a functional ATR-Chk1 pathway. We used functional genetics to dissect the contributions of Chk1 and MK2 to checkpoint control. We show that nuclear Chk1 activity is essential to establish a G(2)/M checkpoint, while cytoplasmic MK2 activity is critical for prolonged checkpoint maintenance through a process of posttranscriptional mRNA stabilization. Following DNA damage, the p38/MK2 complex relocalizes from nucleus to cytoplasm where MK2 phosphorylates hnRNPA0, to stabilize Gadd45α mRNA, while p38 phosphorylates and releases the translational inhibitor TIAR. In addition, MK2 phosphorylates PARN, blocking Gadd45α mRNA degradation. Gadd45α functions within a positive feedback loop, sustaining the MK2-dependent cytoplasmic sequestration of Cdc25B/C to block mitotic entry in the presence of unrepaired DNA damage. Our findings demonstrate a critical role for the MK2 pathway in the posttranscriptional regulation of gene expression as part of the DNA damage response in cancer cells.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932473      PMCID: PMC3030122          DOI: 10.1016/j.molcel.2010.09.018

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  53 in total

1.  Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.

Authors:  Raffaella Di Micco; Marzia Fumagalli; Angelo Cicalese; Sara Piccinin; Patrizia Gasparini; Chiara Luise; Catherine Schurra; Massimiliano Garre'; Paolo Giovanni Nuciforo; Aaron Bensimon; Roberta Maestro; Pier Giuseppe Pelicci; Fabrizio d'Adda di Fagagna
Journal:  Nature       Date:  2006-11-30       Impact factor: 49.962

2.  Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation.

Authors:  Guillermo Barreto; Andrea Schäfer; Joachim Marhold; Dirk Stach; Suresh K Swaminathan; Vikas Handa; Gabi Döderlein; Nicole Maltry; Wei Wu; Frank Lyko; Christof Niehrs
Journal:  Nature       Date:  2007-01-31       Impact factor: 49.962

3.  Phosphorylation of HuR by Chk2 regulates SIRT1 expression.

Authors:  Kotb Abdelmohsen; Rudolf Pullmann; Ashish Lal; Hyeon Ho Kim; Stefanie Galban; Xiaoling Yang; Justin D Blethrow; Mark Walker; Jonathan Shubert; David A Gillespie; Henry Furneaux; Myriam Gorospe
Journal:  Mol Cell       Date:  2007-02-23       Impact factor: 17.970

4.  Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.

Authors:  Ernst ter Haar; Prakash Prabhakar; Prakash Prabakhar; Xun Liu; Christopher Lepre
Journal:  J Biol Chem       Date:  2007-01-25       Impact factor: 5.157

Review 5.  The DNA damage response: ten years after.

Authors:  J Wade Harper; Stephen J Elledge
Journal:  Mol Cell       Date:  2007-12-14       Impact factor: 17.970

6.  Systematic discovery of in vivo phosphorylation networks.

Authors:  Rune Linding; Lars Juhl Jensen; Gerard J Ostheimer; Marcel A T M van Vugt; Claus Jørgensen; Ioana M Miron; Francesca Diella; Karen Colwill; Lorne Taylor; Kelly Elder; Pavel Metalnikov; Vivian Nguyen; Adrian Pasculescu; Jing Jin; Jin Gyoon Park; Leona D Samson; James R Woodgett; Robert B Russell; Peer Bork; Michael B Yaffe; Tony Pawson
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

7.  TAO kinases mediate activation of p38 in response to DNA damage.

Authors:  Malavika Raman; Svetlana Earnest; Kai Zhang; Yingming Zhao; Melanie H Cobb
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

8.  Activation of MTK1/MEKK4 by GADD45 through induced N-C dissociation and dimerization-mediated trans autophosphorylation of the MTK1 kinase domain.

Authors:  Zenshi Miyake; Mutsuhiro Takekawa; Qingyuan Ge; Haruo Saito
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

Review 9.  CDC25 phosphatases in cancer cells: key players? Good targets?

Authors:  Rose Boutros; Valérie Lobjois; Bernard Ducommun
Journal:  Nat Rev Cancer       Date:  2007-07       Impact factor: 60.716

10.  ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Authors:  Shuhei Matsuoka; Bryan A Ballif; Agata Smogorzewska; E Robert McDonald; Kristen E Hurov; Ji Luo; Corey E Bakalarski; Zhenming Zhao; Nicole Solimini; Yaniv Lerenthal; Yosef Shiloh; Steven P Gygi; Stephen J Elledge
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

View more
  100 in total

1.  An ataxia-telangiectasia-mutated (ATM) kinase mediated response to DNA damage down-regulates the mRNA-binding potential of THOC5.

Authors:  Sheetal Ramachandran; Doan Duy Hai Tran; Sabine Klebba-Faerber; Christian Kardinal; Anthony D Whetton; Teruko Tamura
Journal:  RNA       Date:  2011-09-21       Impact factor: 4.942

2.  The ups and downs of DNA repair biomarkers for PARP inhibitor therapies.

Authors:  Xiaozhe Wang; David T Weaver
Journal:  Am J Cancer Res       Date:  2010-01-03       Impact factor: 6.166

Review 3.  Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?

Authors:  H Christian Reinhardt; Ian G Cannell; Sandra Morandell; Michael B Yaffe
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

4.  A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

Authors:  Karl A Merrick; Sandra Morandell; Chang-Qi Zhu; Ian G Cannell; Christian J Braun; Robert A Grant; Eleanor R Cameron; Ming-Sound Tsao; Michael T Hemann; Michael B Yaffe
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743

Review 5.  Exploiting replicative stress to treat cancer.

Authors:  Matthias Dobbelstein; Claus Storgaard Sørensen
Journal:  Nat Rev Drug Discov       Date:  2015-05-08       Impact factor: 84.694

6.  ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.

Authors:  Himjyot Jaiswal; Jan Benada; Erik Müllers; Karen Akopyan; Kamila Burdova; Tobias Koolmeister; Thomas Helleday; René H Medema; Libor Macurek; Arne Lindqvist
Journal:  EMBO J       Date:  2017-06-12       Impact factor: 11.598

Review 7.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

8.  The MAPK-activated protein kinase 2 mediates gemcitabine sensitivity in pancreatic cancer cells.

Authors:  Frederik Köpper; Anna Maria Binkowski; Cathrin Bierwirth; Matthias Dobbelstein
Journal:  Cell Cycle       Date:  2014-02-21       Impact factor: 4.534

Review 9.  Homing in: Mechanisms of Substrate Targeting by Protein Kinases.

Authors:  Chad J Miller; Benjamin E Turk
Journal:  Trends Biochem Sci       Date:  2018-03-12       Impact factor: 13.807

10.  AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.

Authors:  Katja Höpker; Henning Hagmann; Safiya Khurshid; Shuhua Chen; Pia Hasskamp; Tamina Seeger-Nukpezah; Katharina Schilberg; Lukas Heukamp; Tobias Lamkemeyer; Martin L Sos; Roman K Thomas; Drew Lowery; Frederik Roels; Matthias Fischer; Max C Liebau; Ulrike Resch; Tülay Kisner; Fabian Röther; Malte P Bartram; Roman Ulrich Müller; Francesca Fabretti; Peter Kurschat; Björn Schumacher; Matthias Gaestel; René H Medema; Michael B Yaffe; Bernhard Schermer; H Christian Reinhardt; Thomas Benzing
Journal:  EMBO J       Date:  2012-08-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.